摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-2-methyl-N-[(1-methyl-1H-pyrazol-4-yl)methylidene]-2-propanesulfinamide | 1000407-77-1

中文名称
——
中文别名
——
英文名称
(R)-2-methyl-N-[(1-methyl-1H-pyrazol-4-yl)methylidene]-2-propanesulfinamide
英文别名
Rs-2-methyl-propane-2-sulfinic acid 1-methyl-1H-pyrazol-4-yl-methyleneamide;(R,E)-2-methyl-N-((1-methyl-1H-pyrazol-4-yl)methylene)propane-2-sulfinamide;(R)-2-methyl-N-[(1-methylpyrazol-4-yl)methylidene]propane-2-sulfinamide
(R)-2-methyl-N-[(1-methyl-1H-pyrazol-4-yl)methylidene]-2-propanesulfinamide化学式
CAS
1000407-77-1
化学式
C9H15N3OS
mdl
——
分子量
213.304
InChiKey
UOISCRINJGHLGV-CQSZACIVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    66.5
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Diastereoselective In and Zn-mediated allylation of pyrazol-4-yl derived (R)-tert-butanesulfinyl imines: synthesis of enantiomerically pure 6-(pyrazol-4-yl)-piperidin-2,4-diones
    摘要:
    The In and Zn-mediated allylation of substituted pyrazol-4-yl derived (R)-N-tert-butanesulfinyl imines proceeds with high diastereoselectivity depending on the conditions and additives (up to 99.4% de). Thus, the synthesized diastereomeric homoallylsulfinamides were isolated and characterized as pure diastereomers, which were then converted into the corresponding pyrazol-4-yl-derived N-Boc-homoallylamines via consecutive treatment with HCl and Boc(2)O. The latter were then subjected to a sequence of reactions: cyclobromocarbamation with NBS and enolateisocyanate rearrangement with tBuOK to give novel enantiomerically pure (S)-6-(pyrazol-4-yl)-piperidine-2,4-diones in 88-96% yield. The absolute configurations of the allylation products were assigned by X-ray single crystal analysis of the intermediate bromomethylurethanes. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2014.03.003
  • 作为产物:
    描述:
    1-甲基-1H-吡唑-4-甲醛(R)-(+)-叔丁基亚磺酰胺titanium(IV) isopropylate 作用下, 以 四氢呋喃 为溶剂, 反应 20.0h, 以97%的产率得到(R)-2-methyl-N-[(1-methyl-1H-pyrazol-4-yl)methylidene]-2-propanesulfinamide
    参考文献:
    名称:
    Diastereoselective In and Zn-mediated allylation of pyrazol-4-yl derived (R)-tert-butanesulfinyl imines: synthesis of enantiomerically pure 6-(pyrazol-4-yl)-piperidin-2,4-diones
    摘要:
    The In and Zn-mediated allylation of substituted pyrazol-4-yl derived (R)-N-tert-butanesulfinyl imines proceeds with high diastereoselectivity depending on the conditions and additives (up to 99.4% de). Thus, the synthesized diastereomeric homoallylsulfinamides were isolated and characterized as pure diastereomers, which were then converted into the corresponding pyrazol-4-yl-derived N-Boc-homoallylamines via consecutive treatment with HCl and Boc(2)O. The latter were then subjected to a sequence of reactions: cyclobromocarbamation with NBS and enolateisocyanate rearrangement with tBuOK to give novel enantiomerically pure (S)-6-(pyrazol-4-yl)-piperidine-2,4-diones in 88-96% yield. The absolute configurations of the allylation products were assigned by X-ray single crystal analysis of the intermediate bromomethylurethanes. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2014.03.003
点击查看最新优质反应信息

文献信息

  • SERINE/THREONINE KINASE INHIBITORS
    申请人:Blake Jim
    公开号:US20140066453A1
    公开(公告)日:2014-03-06
    Compounds having the formula I wherein R 2 , X and Z as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.
    具有公式I的化合物,其中R2、X和Z如本文所定义,是ERK激酶的抑制剂。还披露了用于治疗过度增殖性疾病的组合物和方法。
  • WO2008/834
    申请人:——
    公开号:——
    公开(公告)日:——
  • SERINE/THREONINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
    申请人:Array Biopharma, Inc.
    公开号:EP2888247B1
    公开(公告)日:2020-03-25
  • US9388171B2
    申请人:——
    公开号:US9388171B2
    公开(公告)日:2016-07-12
查看更多